1 unknown. 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 1 | Unknown 1 |
Follow Pharming Technologies B.V.: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| An Open-Label Study to Assess the Safety & Efficacy of Leniolisib in Japanese Patients With APDS Leniolisib - APDS Gene Mutation | Phase 3 | Unknown | Pharming Technologies B.V. | 3 | 2023-08-03 | 2024-02-08 |
leniolisib (1)
Japan (1)